Details
Stereochemistry | ACHIRAL |
Molecular Formula | CO2 |
Molecular Weight | 44.0095 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C=O
InChI
InChIKey=CURLTUGMZLYLDI-UHFFFAOYSA-N
InChI=1S/CO2/c2-1-3
Molecular Formula | CO2 |
Molecular Weight | 44.0095 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Carbon dioxide is a colorless gas occurring naturally in Earth's atmosphere. Carbon dioxide is a primary carbon source for life on Earth. It is produced by all aerobic organisms during metabolism of carbohydrates and lipids. Carbon dioxide is used in food industry as an acidity regulator and for production of carbonated soft drinks and soda water. In medicine, carbon dioxide is commonly used as an insufflation gas for minimally invasive surgery (laparoscopy, endoscopy, and arthroscopy) to enlarge and stabilize body cavities to provide better visibility of the surgical area. A mixture of carbon dioxide and oxygen is used for stimulation of breathing after apnea, in anesthetic procedures to increase the depth of respiration, to facilitate blind intubations in anesthetic practice.
CNS Activity
Sources: https://www.boconline.co.uk/internet.lg.lg.gbr/en/images/medical_carbon_dioxide410_56027.pdf?v=2.0
Curator's Comment: Carbon dioxide is naturally produced in all tissues.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseCarbon dioxide is used to stimulate respiration after a period of apnoea |
|||
Primary | Unknown Approved UseCarbon dioxide is used in chronic respiratory obstruction after it has been relieved |
|||
Palliative | Unknown Approved UseCarbon dioxide is used to increase cerebral blood flow in arteriosclerotic patients undergoing surgery |
PubMed
Title | Date | PubMed |
---|---|---|
Oxidative degradation of phenanthrene by the ligninolytic fungus Phanerochaete chrysosporium. | 1992 Jun |
|
Crystal structure of NAD-dependent formate dehydrogenase. | 1992 Jun 1 |
|
Degradation of 2,4-dinitrophenol by two Rhodococcus erythropolis strains, HL 24-1 and HL 24-2. | 1992 Sep |
|
[Comparative estimation of effectiveness of nonsteroidal anti-inflammatory drugs used for postoperative pain management]. | 2003 |
|
[Effectiveness of ketonal and diclofenac in spondylarthrosis complicated with spinal pain]. | 2003 |
|
Mutation induced modulation of hydrogen bonding to P700 studied using FTIR difference spectroscopy. | 2003 Aug 26 |
|
[Effect of premedication on the formation of postoperative pain syndrome]. | 2003 Jul-Aug |
|
Laser-assisted uvulopalatoplasty for the treatment of snoring and mild obstructive sleep apnea syndrome. | 2003 Jun |
|
High-sensitivity photoacoustic leak testing. | 2003 Oct |
|
Identification of intramembrane hydrogen bonding between 13(1) keto group of bacteriochlorophyll and serine residue alpha27 in the LH2 light-harvesting complex. | 2003 Oct 17 |
|
Energy cost and cardiorespiratory changes during the practice of Surya Namaskar. | 2004 Apr |
|
Anesthesiological hazards during laparoscopic transhiatal esophageal resection: a case control study of the laparoscopic-assisted vs the conventional approach. | 2004 Aug |
|
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma. | 2004 Dec |
|
Tretinoin treatment before carbon-dioxide laser resurfacing: a clinical and biochemical analysis. | 2004 Dec |
|
Isolation and characterization of a novel sphingomonad capable of growth with chrysene as sole carbon and energy source. | 2004 Dec 15 |
|
Dynamic co-evolution of peptides and chemical energetics, a gateway to the emergence of homochirality and the catalytic activity of peptides. | 2004 Feb |
|
CO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2. | 2004 Jan 20 |
|
Supercritical carbon dioxide extraction of selected medicinal plants--effects of high pressure and added ethanol on yield of extracted substances. | 2004 Jan-Feb |
|
Influence of the organophosphorus insecticide phosphamidon on lentic water. | 2004 Jul |
|
Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. | 2004 Jul |
|
Supercritical carbon dioxide extraction of chamomile flowers: extraction efficiency, stability, and in-line inclusion of chamomile-carbon dioxide extract in beta-cyclodextrin. | 2004 Jul-Aug |
|
Direct determination of carbon dioxide in aqueous solution using mid-infrared quantum cascade lasers. | 2004 Jun |
|
Use of CO2/O2 anesthesia in the collection of samples for serum corticosterone analysis from Fischer 344 rats. | 2004 Mar |
|
Enzymatic reactions in anaerobic 2-methylnaphthalene degradation by the sulphate-reducing enrichment culture N 47. | 2004 Nov 1 |
|
Meerwein-Ponndorf-Verley alkynylation of aldehydes: essential modification of aluminium alkoxides for rate acceleration and asymmetric synthesis. | 2004 Nov 21 |
|
Role of tyrosine phosphorylation in sperm capacitation / acrosome reaction. | 2004 Nov 9 |
|
Metabolism of 2-mercaptobenzothiazole by Rhodococcus rhodochrous. | 2004 Oct |
|
Photochemical preparation of highly functionalized 1-indanones. | 2004 Oct 29 |
|
Difference between diabetic and nondiabetic smokers in the pituitary response to physical exercise. | 2004 Sep |
|
Retention characteristics of porous graphitic carbon in subcritical fluid chromatography with carbon dioxide-methanol mobile phases. | 2004 Sep 3 |
|
Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model. | 2005 |
|
Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder. | 2005 |
|
Coupling aggressive mass removal with microbial reductive dechlorination for remediation of DNAPL source zones: a review and assessment. | 2005 Apr |
|
Isolation and characterization of a rhodococcus species strain able to grow on ortho- and para-xylene. | 2005 Aug |
|
Metabolism of the aliphatic nitramine 4-nitro-2,4-diazabutanal by Methylobacterium sp. strain JS178. | 2005 Aug |
|
Optical-fiber-to-waveguide coupling using carbon-dioxide-laser-induced long-period fiber gratings. | 2005 Aug 15 |
|
Laryngeal amyloidosis. | 2005 Feb |
|
Angiokeratoma circumscriptum naeviforme: successful treatment with carbon-dioxide laser vaporization. | 2005 Feb |
|
A1 reduction in intact cyanobacterial photosystem I particles studied by time-resolved step-scan Fourier transform infrared difference spectroscopy and isotope labeling. | 2005 Feb 15 |
|
Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing. | 2005 Jan |
|
[Development of gastrotonometry and the future of its use in the monitoring of critically ill patients]. | 2005 Jan 23 |
|
Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. | 2005 Jul |
|
Strong effects of an individual water molecule on the rate of light-driven charge separation in the Rhodobacter sphaeroides reaction center. | 2005 Jul 22 |
|
Physico-chemical characteristics of Anopheles culicifacies and Anopheles varuna breeding water in a dry zone stream in Sri Lanka. | 2005 Jun |
|
Identification of 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid, 4-hydroxy-2-oxohexanoic acid, and 2-hydroxyhexa-2,4-dienoic acid and related enzymes involved in testosterone degradation in Comamonas testosteroni TA441. | 2005 Sep |
|
Pictet-Spengler reactions in multiphasic supercritical carbon dioxide/CO2-expanded liquid media. In situ generation of carbamates as a strategy for reactions of amines in supercritical carbon dioxide. | 2005 Sep 21 |
|
Differentiation of human bone marrow stem cells into cells with a neural phenotype: diverse effects of two specific treatments. | 2006 Feb 16 |
|
Ultrafast transient absorption studies on photosystem I reaction centers from Chlamydomonas reinhardtii. 2: mutations near the P700 reaction center chlorophylls provide new insight into the nature of the primary electron donor. | 2006 Jan 15 |
|
Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice. | 2006 Mar |
|
Characterisation of stationary phases in subcritical fluid chromatography with the solvation parameter model. III. Polar stationary phases. | 2006 Mar 31 |
Patents
Sample Use Guides
Carbon dioxide is usually administered through the lungs by inhalation. The major exceptions are when a metered supply is fed into the oxygenator of an extracorporeal circulation of a cardiopulmonary bypass system, and when the gas is used for laparoscopic surgery. As an additive to beverages, carbon dioxide is consumed orally.
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:39:24 UTC 2023
by
admin
on
Fri Dec 15 15:39:24 UTC 2023
|
Record UNII |
142M471B3J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
16551-4
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
13538-4
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
59165-1
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
28644-3
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
NDF-RT |
N0000180185
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
14640-7
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
51781-3
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
39465-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
77143-6
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
NDF-RT |
N0000010258
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2021-4
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2020-6
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
35685-7
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
13541-8
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
41647-9
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2018-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2028-9
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
39464-3
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
32306-3
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
JECFA EVALUATION |
INS-290
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
WHO-ATC |
A06AX02
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
19212-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
CFR |
21 CFR 862.1160
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
39466-8
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-290
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
28645-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
57920-1
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
53089-9
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
34520-7
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
48391-7
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2022-2
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
EPA PESTICIDE CODE |
16601
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2027-1
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
13540-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
11557-6
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
38253-1
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
WHO-VATC |
QA06AX02
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
34728-6
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
14040-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
57922-7
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
FDA ORPHAN DRUG |
465114
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
57923-5
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2026-3
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
20565-8
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
DSLD |
3848 (Number of products:1)
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
53458-6
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
57921-9
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
53090-7
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2019-8
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
19223-7
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
CFR |
21 CFR 184.1240
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
2023-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
WHO-VATC |
QV03AN02
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
11211-0
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
LOINC |
14003-8
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
||
|
WHO-ATC |
V03AN02
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4256
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
100000076280
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
DB09157
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
124-38-9
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
DTXSID4027028
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
m3079
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | Merck Index | ||
|
516
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
CHEMBL1231871
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
CARBON DIOXIDE
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
280
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
D002245
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
C65288
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
2034
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB13243MIG
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
16526
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY | |||
|
204-696-9
Created by
admin on Fri Dec 15 15:39:24 UTC 2023 , Edited by admin on Fri Dec 15 15:39:24 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
CARBON DIOXIDE (% Vol.)
Non-filtered cigarette(85 mm) Univ Kentucky- 9.4 Filtered cigarette(85 mm) New Yorl City- 9.6 Little cigars A(85 mm) Boston-8.5 Little cigars B (85 mm),New York City-13.2 Small cigars C(95 mm),New York City-12.7
|
||
|
SUB_CONCEPT->SUBSTANCE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
Unit: percent of total dose excreted (into Expired Air; 39.7% to 58.6%)
IN-VIVO
|
||
|
PARENT -> METABOLITE |
MAJOR
EXHALATION
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |